Latest From Biotech Now

From a Farmer’s Mouth “Why GMOs Deserve Our Trust”

Switchgrass

When it comes to such a contentious issue as GMO labeling, the focus is often placed on the consumer. “Consumers have the right to know what’s in their food, transparency for consumers, consumers should have choice, etc.” However, we often forget about how GMO labeling will impact those who grow our food. The food supply chain in the United States relies on a system of commingling, grain delivered to the elevator by farmers throughout the Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Becoming a Master in All Things Related to the Bioeconomy

innogen

In 2002, the ESRC Centre for Social and Economic Research on Innovation in Genomics (Innogen) was formed to study the evolution of genomics and life sciences and their far-reaching social and economic implications. As part of the ESRC Genomics Network, Innogen’s research provided a sound base for decision-making in science, industry, policy and public arenas related to the life sciences. Building on this strong body of work, the ESRC Innogen Centre laid the foundation for Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Apple is “Now Better Thanks to Genetic Modification”

Arctic Apple

In a recent editorial, the Wall Street Journal discusses whether or not the recently USDA approved genetically engineered apple, Arctic® Apple, and potato, Innate™ potato, can win customers amid fear and loathing from interest groups that sow distrust of genetically modified foods, or GMOs. …Arctic and Innate are among the first genetically modified foods pitched in part to consumers, rather than directly to farmers dealing with drought or pests. Like all genetically engineered foods, they’ve undergone extensive safety testing. Arctic apples could help grocery stores Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Coalition Offers a Remedy for Stagnated Clinical Trials

lab_tech

Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A new medication seems to be slowing the disease’s progress, limiting the cognitive decline that characterizes this “long goodbye.” Wouldn’t it be wonderful for patients suffering other diseases to have equally encouraging prospects? But many do not. Part of the problem lies with clinical trials.  For a new medication to receive FDA approval, it must undergo comprehensive testing on actual patients.  Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

What to Watch: Emperor of All Maladies; Killing Cancer

Annie Cavanagh. Wellcome Images

Cancer is a disease which affects almost 1.7 million people each year in America, and is the fastest growing disease on Earth. Two television shows this week explore the history of the complex illness, as well as recent treatment advances that are providing new hope for many patients. The first is a television adaptation of Siddhartha Mukherjee’s The Emperor of All Maladies: A Biography of Cancer, which won the Pulitzer Prize for Nonfiction. The TV Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,